|
|
|
Volumn 2, Issue 3, 2000, Pages 228-235
|
|
Natalizumab Elan
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTEGRIN;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
UNCLASSIFIED DRUG;
VASCULAR CELL ADHESION MOLECULE 1;
VERY LATE ACTIVATION ANTIGEN;
CLINICAL TRIAL;
DRUG MECHANISM;
DRUG SYNTHESIS;
HUMAN;
LICENSING;
LYMPHOCYTOSIS;
MULTIPLE SCLEROSIS;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REVIEW;
TREATMENT OUTCOME;
|
|
EID: 0033922107
PISSN: 14648474
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (115)
|
